Diagnostic and therapeutic challenges.
Dinç
Umut Asl
UA
Department of Ophthalmology, Yeditepe University Eye Hospital, Istanbul, Turkey.
Yenerel
Nursal Melda
NM
Görgün
Ebru
E
Yetik
Huseyin
H
Kokame
Gregg T
GT
Lim
Jennifer I
JI
D000086:Acetazolamide / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003930:Diabetic Retinopathy / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D017075:Laser Coagulation; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012160:Retina / Q000187:drug effects* / Q000473:pathology; D013449:Sulfonamides / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000502:physiology
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D002257:Carbonic Anhydrase Inhibitors; D005938:Glucocorticoids; D013449:Sulfonamides; D013843:Thiazines; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; C111827:brinzolamide; D014222:Triamcinolone Acetonide; D000086:Acetazolamide